SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Capital Work in Progress | - | - | ₹26 Cr | ₹6.20 Cr | ₹0.25 Cr |
What is the latest Capital Work in Progress ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹6.20 Cr |
| Mar2017 | ₹0.25 Cr |
How is Capital Work in Progress of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹26 Cr | 312.61 | |
| Mar2022 | ₹6.20 Cr | 2,420.73 | |
| Mar2017 | ₹0.25 Cr | - | |
Compare Capital Work in Progress of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,327.3 Cr | 2.2% | 3.4% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,195.0 Cr | 0.9% | 12.7% | 8.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,993.0 Cr | -0.4% | 9.7% | 11.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,926.0 Cr | 0.5% | 5.8% | 36.5% | Stock Analytics | |
| CIPLA | ₹113,052.0 Cr | -2.7% | 13.9% | -6.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,333.0 Cr | 1.5% | 7.3% | 8% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 2.2% |
3.4% |
-16.3% |
| SENSEX | 1% |
-4.1% |
-7.4% |
You may also like the below Video Courses